Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026
Source: SeekingAlpha
2026-03-31 15:43:21 ET
More on Imunon
- Imunon, Inc. (IMNN) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Imunon
- Historical earnings data for Imunon
- Financial information for Imunon
Read the full article on Seeking Alpha
For further details see:
Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026
Imunon Inc.
NASDAQ: IMNN
IMNN Trading
0.48% G/L:
$2.09 Last:
62,604 Volume:
$2.17 Open:
IMNN Latest News
May 12, 2026 08:00:00 am
IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update
IMNN Stock Data
$11,164,462
3,034,410
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Lawrenceville
